The Lancet. Oncology Journal

Overview
Identity
View All

publication venue for

SunRISe-4 perioperative safety and TURBT stratification - Authors' reply.. 26:-. 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial.. 26:1312-1322. 2025
Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis.. 26:1252-1260. 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.. 26:1018-1030. 2025
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.. 23:27-52. 2021
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.. 22:1721-1731. 2021
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.. 22:1507-1517. 2021
Immunotherapy in ovarian cancer: we are not there yet.. 22:903-905. 2021
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.. 22:632-642. 2021
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.. 22:620-631. 2021
The effect of non-AIDS-defining cancers on people living with HIV.. 22:e240-e253. 2021
Fulvestrant plus capivasertib for metastatic breast cancer.. 21:-. 2020
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017.. 20:1211-1225. 2019
Trifluridine/tipiracil in metastatic gastric cancer.. 20:-. 2019
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.. 18:1274-1284. 2017
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.. 17:1579-1589. 2016
Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis.. 15:1027-38. 2014
Recognition of surgical need as part of cancer control in Africa.. 14:-. 2013
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.. 14:749-59. 2013
Keynote comment: cancer survivorship and ageing--a double whammy.. 7:882-3. 2006